Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States-Reference-Cited by-同舟云学术

Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States

Published:2018-03-05 Issue:10 Volume:124 Page:2104-2114
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Schwartz Kendra L.¹²,Simon Michael S.²³^ORCID,Bylsma Lauren C.⁴^ORCID,Ruterbusch Julie J.²³,Beebe-Dimmer Jennifer L.²³,Schultz Neil M.⁵,Flanders Scott C.⁵,Barlev Arie⁶,Fryzek Jon P.⁷,Quek Ruben G.W.⁶

Affiliation:

1. Department of Family Medicine and Public Health Sciences, School of Medicine; Wayne State University; Detroit Michigan

2. Barbara Ann Karmanos Cancer Institute; Detroit Michigan

3. Department of Oncology, School of Medicine; Wayne State University; Detroit Michigan

4. EpidStat Institute; Ann Arbor Michigan

5. Astellas Pharma Inc; Northbrook Illinois

6. Pfizer Inc; San Francisco California

7. EpidStat Institute; Rockville Maryland

Funder

Medivation LLC

Pfizer

Astellas Pharma Inc